We are currently experiencing a biotech “boom,” with biotech investing recently reaching an all-time high . 2015’s numbers are positioned to easily surpass 2014’s total… Read more
Nsight Barbara Nelsen on the business of science.
Successfully bringing cell therapies to more patients will require the development of manufacturing solutions that are efficient and cost-effective, and that allow for the stringent… Read more